Carlos A A Sariol (Carlos A Sariol)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

African American

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

Nature communications

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ana M M Espino, Albersy Armina-Rodríguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A A Sariol
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses 16 (2) (2024)
Ana M M Espino, Albersy Armina-Rodríguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A A Sariol
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses 16 (2) (2024)
Ana M M Espino, Albersy Armina-Rodríguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A A Sariol
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses 16 (2) (2024)
Ana M M Espino, Albersy Armina-Rodríguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A A Sariol
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses 16 (2) (2024)
Ana M M Espino, Albersy Armina-Rodríguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I Rodriguez Martinó, Paola López-Marte, Esther A Torres, Carlos A A Sariol
The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer-BioNTech Vaccine. Viruses 16 (2) (2024)
Mitchell R Sanchez Rosado, Nicole Marzan-Rivera, Marina M Watowich, Andrea D Negron-Del Valle, Petraleigh Pantoja, Melissa A Pavez-Fox, Erin R Siracusa, Eve B Cooper, Josue E Negron-Del Valle, Daniel Phillips, Angelina V Ruiz-Lambides, null null, Melween I Martinez, Michael J Montague, Michael Louis Platt, James P Higham, Lauren J N Brent, Carlos A A Sariol, Noah James Snyder-Mackler
Immune cell composition varies by age, sex and exposure to social adversity in free-ranging Rhesus Macaques. GeroScience (2023)
Ellen F Young, Boyd Yount, Petraleigh Pantoja, Sandra Henein, Rita M Meganck, Jennifer McBride, Jennifer E Munt, Thomas J Baric, Deanna Zhu, Trevor Scobey, Stephanie Dong, Longping V Tse, Melween I Martinez, Armando G Burgos, Rachel L Graham, Laura White, Aravinda DeSilva, Carlos A A Sariol, Ralph S Baric
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity. Nature communications 14 (1) (2023)
Ellen F Young, Boyd Yount, Petraleigh Pantoja, Sandra Henein, Rita M Meganck, Jennifer McBride, Jennifer E Munt, Thomas J Baric, Deanna Zhu, Trevor Scobey, Stephanie Dong, Longping V Tse, Melween I Martinez, Armando G Burgos, Rachel L Graham, Laura White, Aravinda DeSilva, Carlos A A Sariol, Ralph S Baric
A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity. Nature communications 14 (1) (2023)
Paola López-Marte, Alondra Soto-González, Lizzie Ramos-Tollinchi, Stephan Torres-Jorge, Mariana Ferre, Esteban Rodríguez-Martinó, Esther A Torres, Carlos A A Sariol
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose. Vaccines 10 (8) (2022)
Esteban Rodríguez-Martinó, Rafael Medina-Prieto, Jorge Santana-Bagur, María Santé, Petraleigh Pantoja, Ana M Espino, Carlos A A Sariol, Esther A Torres
Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators. medRxiv : the preprint server for health sciences (2021)
Carlos A A Sariol, Crisanta Serrano-Collazo, Edwin J Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana M Espino
Limited impact of Delta variantâ€™s mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population. medRxiv : the preprint server for health sciences (2021)
Carlos A A Sariol, Crisanta Serrano-Collazo, Edwin J Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, Dianne Atehortua, Christina Pabon-Carrero, Ana M M Espino
Limited Impact of Delta Variant's Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population. Viruses 13 (12) (2021)
Carlos A A Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, Tiffany Rosa-Arocho, Albersy Armina-Rodríguez, Lorna Cruz, E Taylor Taylor Stone, Teresa Arana, Consuelo Climent, Gerardo Latoni, Dianne Atehortua, Christina Pabon-Carrero, Amelia K K Pinto, James D D Brien, Ana M M Espino
Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination. Viruses 13 (10) (2021)
Crisanta Serrano-Collazo, Erick X Pérez-Guzmán, Petraleigh Pantoja, Mariah A Hassert, Idia V Rodríguez, Luis D Giavedoni, Vida Hodara, Laura Parodi, Lorna Cruz, Teresa Arana, Melween I Martínez, Laura White, James D Brien, Aravinda de Silva, Amelia K Pinto, Carlos A A Sariol
Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies. PLoS neglected tropical diseases 14 (5) (2020)
Erick X Pérez-Guzmán, Petraleigh Pantoja, Crisanta Serrano-Collazo, Mariah A Hassert, Alexandra Ortiz-Rosa, Idia V Rodríguez, Luis Giavedoni, Vida Hodara, Laura Parodi, Lorna Cruz, Teresa Arana, Laura J White, Melween I Martínez, Daniela Weiskopf, James D Brien, Aravinda de Silva, Amelia K Pinto, Carlos A A Sariol
Time elapsed between Zika and dengue virus infections affects antibody and T cell responses. Nature communications 10 (1) (2019)